The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval.

Ryusuke NakamotoCaitlyn HarrisonHong SongKip E GujaNegin HatamiJudy NguyenFarshad MoradiBenjamin Lewis FrancCarina Mari ApariciGuido DavidzonAndrei H Iagaru

Published in: Molecular imaging and biology (2021)

18F-Fluciclovine PET/CT remains a useful diagnostic tool in the workup of patients with BCR PC, changing clinical management in 62 % of participants in our cohort.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
acute lymphoblastic leukemia
positron emission tomography
chronic myeloid leukemia
computed tomography
drug administration